Susumu Kitamura

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

Robert Altman, L Carreras, Rubén Sierra Díaz et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1994 · 3.3K citations

Thrombosis, Ischemic Stroke, Cardiovascular Disease +9

Efficacy and safety of risankizumab in Japanese patients with moderate to severe plaque psoriasis: Results from the Susta<scp>IMM</scp> phase 2/3 trial

Mamitaro Ohtsuki, Hideki Fujita, Keiko Suzaki et al. · The Journal of Dermatology · 2019 · 92 citations · Full text

Adalimumab treatment in Japanese patients with generalized pustular psoriasis: Results of an open‐label phase 3 study

Akimichi Morita, Fumikazu Yamazaki, Takashi Matsuyama et al. · The Journal of Dermatology · 2018 · 67 citations · Full text

Efficacy and safety of upadacitinib in Japanese patients with rheumatoid arthritis (SELECT-SUNRISE): a placebo-controlled phase IIb/III study

Hideto Kameda, Tsutomu Takeuchi, Kunihiro Yamaoka et al. · Lara D. Veeken · 2020 · 61 citations · Full text

Twenty‐four‐week interim analysis from a phase 3 open‐label trial of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa

Akimichi Morita, Hidetoshi Takahashi, Kentaro Ozawa et al. · The Journal of Dermatology · 2019 · 17 citations · Full text